nicotinamide mononucleotide has been researched along with Acute Kidney Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, R; Gao, M; Hu, X; Li, Y; Wang, Y; Zeng, J; Zhang, R | 1 |
| Guan, Y; Hao, CM; Huang, XZ; Shang, D; Wang, SR; Xie, QH; Xu, YY | 1 |
2 other study(ies) available for nicotinamide mononucleotide and Acute Kidney Injury
| Article | Year |
|---|---|
Reversing Acute Kidney Injury through Coordinated Interplay of Anti-Inflammation and Iron Supplementation.
Topics: Acute Kidney Injury; Anti-Inflammatory Agents; Dietary Supplements; Humans; NAD; Nicotinamide Mononucleotide; Reactive Oxygen Species | 2023 |
Nicotinamide Mononucleotide, an NAD
Topics: Acute Kidney Injury; Age Factors; Animals; Disease Susceptibility; JNK Mitogen-Activated Protein Kinases; Mice; NAD; Nicotinamide Mononucleotide; Sirtuin 1 | 2017 |